EP4743111A1 - Pharmaceutical compositions and methods for the treatment of fungal infections - Google Patents

Pharmaceutical compositions and methods for the treatment of fungal infections

Info

Publication number
EP4743111A1
EP4743111A1 EP24840524.3A EP24840524A EP4743111A1 EP 4743111 A1 EP4743111 A1 EP 4743111A1 EP 24840524 A EP24840524 A EP 24840524A EP 4743111 A1 EP4743111 A1 EP 4743111A1
Authority
EP
European Patent Office
Prior art keywords
treatment
methods
pharmaceutical compositions
fungal infections
fungal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP24840524.3A
Other languages
German (de)
French (fr)
Inventor
Chaoyang Xue
Amariliz Rivera
Yina Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rutgers State University of New Jersey
Original Assignee
Rutgers State University of New Jersey
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rutgers State University of New Jersey filed Critical Rutgers State University of New Jersey
Publication of EP4743111A1 publication Critical patent/EP4743111A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0002—Fungal antigens, e.g. Trichophyton, Aspergillus, Candida
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
EP24840524.3A 2023-07-11 2024-07-11 Pharmaceutical compositions and methods for the treatment of fungal infections Pending EP4743111A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202363513029P 2023-07-11 2023-07-11
PCT/US2024/037496 WO2025015118A1 (en) 2023-07-11 2024-07-11 Pharmaceutical compositions and methods for treating fungal infections

Publications (1)

Publication Number Publication Date
EP4743111A1 true EP4743111A1 (en) 2026-05-20

Family

ID=94216436

Family Applications (1)

Application Number Title Priority Date Filing Date
EP24840524.3A Pending EP4743111A1 (en) 2023-07-11 2024-07-11 Pharmaceutical compositions and methods for the treatment of fungal infections

Country Status (2)

Country Link
EP (1) EP4743111A1 (en)
WO (1) WO2025015118A1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2314099T3 (en) * 2001-08-17 2009-03-16 Coley Pharmaceutical Gmbh IMMUNO STIMULANT OLIGONUCLEOTIDES WITH REASONS COMBINED WITH IMPROVED ACTIVITY.
AU2010229835B2 (en) * 2009-03-25 2015-01-15 The Board Of Regents Of The University Of Texas System Compositions for stimulation of mammalian innate immune resistance to pathogens
US12115213B2 (en) * 2016-07-11 2024-10-15 Rutgers, The State University Of New Jersey Methods of treating fungal infections

Also Published As

Publication number Publication date
WO2025015118A9 (en) 2025-09-18
WO2025015118A1 (en) 2025-01-16

Similar Documents

Publication Publication Date Title
EP4373939A4 (en) GENOMEDITATION COMPOSITIONS AND METHODS FOR THE TREATMENT OF CHRONIC GRANULOMATOSIC DISEASE
EP4196113A4 (en) PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THE TREATMENT OF PARKINSON'S DISEASE
EP4415755A4 (en) ACE2-TARGETED COMPOSITIONS AND METHODS FOR THE TREATMENT OF COVID-19
EP4401792A4 (en) Compositions and methods for the treatment of facioscapulohumeral muscle dystrophy
EP4204443A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF GLIOBLASTOMA
EP4413137A4 (en) Compositions and methods for the treatment of recurrent CAG diseases
EP4151227A4 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF CANCER
EP4337174A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF VIRAL INFECTIONS
EP4438048A4 (en) Pharmaceutical composition for the treatment or prevention of T-cell-related diseases
EP3636281A4 (en) METHOD OF TREATMENT OF DEPRESSION AND PHARMACEUTICAL COMPOSITION
EP4408464A4 (en) Methods for treating cancer and pharmaceutical compositions thereof
EP4340860A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF NEUROPATHY
EP4188346A4 (en) NOBILETIN COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF COVID-19 AND RELATED DISEASES
EP4277613A4 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF BREAST CANCER AND METHODS OF USE THEREOF
EP3958863C0 (en) NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF KIDNEY DISEASES
EP4478887A4 (en) NEW PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THE TREATMENT OF INSTALLATION
EP4419144A4 (en) Compositions and methods for the treatment of muscle dystrophy
EP4262763A4 (en) SMAC-MIMETICS FOR THE TREATMENT OF CANCER, METHOD FOR THE PRODUCTION AND PHARMACEUTICAL COMPOSITION THEREOF
EP4185319A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF OCULAR DISEASES
EP4121084A4 (en) COMPOSITIONS FOR THE TREATMENT OF RESPIRATORY INFECTIONS AND USES THEREOF
EP4551220A4 (en) Pharmaceutical compositions and methods for the treatment of insomnia
EP4565237A4 (en) Pharmaceutical compositions and uses thereof for the treatment of gliomas
EP4452295A4 (en) Pharmaceutical composition for the treatment of viral infections
EP4408532A4 (en) Compositions and methods for the treatment of PCDH19-related diseases
EP4582087A4 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF LYMPHOMAS

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE